Omeros (OMER) Change in Accured Expenses (2010 - 2026)
Omeros recorded quarterly Change in Accured Expenses of -$979000.0 in Q1 2026, up 44.15% quarter-over-quarter from -$1.8 million in Q4 2025, and up 80.58% year-over-year from -$542132.7 in Q1 2025.
Omeros' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$979000.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 80.58% year-over-year to -$979000.0; the TTM figure through Mar 2026 stood at $8.6 million (up 263.61% YoY), while the FY2025 annual figure was $4.6 million, up 187.46% from the prior year.
- Change in Accured Expenses came in at -$979000.0 for Q1 2026 at Omeros, up from -$1.8 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $8.2 million in Q2 2025 to a low of -$15.7 million in Q1 2022.
- A 5-year average of -$448176.5 and a median of $879000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses sank 781.72% in 2024 and surged 1336.43% in 2025, its largest moves.
- Omeros' Change in Accured Expenses stood at $879000.0 in 2022, then gained by 7.05% to $941000.0 in 2023, then surged by 544.63% to $6.1 million in 2024, then plunged by 128.9% to -$1.8 million in 2025, then surged by 44.15% to -$979000.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$979000.0, -$1.8 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | -979,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -979,000.00 |
| Mar 31, 2026 | -979,000.00 |
| Dec 31, 2025 | -1.75 Mn |
| Dec 31, 2025 | -1.75 Mn |
| Sep 30, 2025 | 3.13 Mn |
| Sep 30, 2025 | 3.13 Mn |
| Jun 30, 2025 | 8.25 Mn |
| Jun 30, 2025 | 8.25 Mn |
| Mar 31, 2025 | -5.04 Mn |
| Mar 31, 2025 | -5.04 Mn |
| Dec 31, 2024 | 6.07 Mn |
| Dec 31, 2024 | 6.07 Mn |
| Sep 30, 2024 | -5.64 Mn |
| Sep 30, 2024 | -5.64 Mn |
| Jun 30, 2024 | -667,000.00 |
| Jun 30, 2024 | -667,000.00 |
| Mar 31, 2024 | -5.00 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Dec 31, 2023 | 941,000.00 |
| Dec 31, 2023 | 941,000.00 |
| Sep 30, 2023 | 982,000.00 |
| Sep 30, 2023 | 982,000.00 |
| Jun 30, 2023 | 2.03 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | 733,000.00 |
| Mar 31, 2023 | 733,000.00 |
| Dec 31, 2022 | 879,000.00 |
| Dec 31, 2022 | 879,000.00 |
| Sep 30, 2022 | 1.11 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 3.02 Mn |
| Jun 30, 2022 | 3.02 Mn |
| Mar 31, 2022 | -15.67 Mn |
| Mar 31, 2022 | -15.67 Mn |
| Dec 31, 2021 | 9.84 Mn |
| Dec 31, 2021 | 9.84 Mn |
| Sep 30, 2021 | -5.07 Mn |
| Sep 30, 2021 | -5.07 Mn |
| Jun 30, 2021 | 3.31 Mn |
| Jun 30, 2021 | 3.31 Mn |
| Mar 31, 2021 | 6.56 Mn |
| Mar 31, 2021 | 6.56 Mn |
| Dec 31, 2020 | -11.03 Mn |
| Dec 31, 2020 | -11.03 Mn |
| Sep 30, 2020 | 9.52 Mn |
| Sep 30, 2020 | 9.52 Mn |
| Jun 30, 2020 | -20.07 Mn |
| Jun 30, 2020 | -20.07 Mn |
| Mar 31, 2020 | 1.85 Mn |
| Mar 31, 2020 | 1.85 Mn |
| Dec 31, 2019 | 6.36 Mn |
| Dec 31, 2019 | 6.36 Mn |
| Sep 30, 2019 | 5.07 Mn |
| Sep 30, 2019 | 5.07 Mn |
| Jun 30, 2019 | -4.04 Mn |
| Jun 30, 2019 | -4.04 Mn |
| Mar 31, 2019 | 5.88 Mn |
| Mar 31, 2019 | 5.88 Mn |
| Dec 31, 2018 | 12.29 Mn |
| Dec 31, 2018 | 12.29 Mn |
| Sep 30, 2018 | 64,000.00 |
| Sep 30, 2018 | 64,000.00 |
| Jun 30, 2018 | -412,000.00 |
| Jun 30, 2018 | -412,000.00 |
| Mar 31, 2018 | -1.84 Mn |
| Mar 31, 2018 | -1.84 Mn |
| Dec 31, 2017 | 1.38 Mn |
| Dec 31, 2017 | 1.38 Mn |
| Sep 30, 2017 | -283,000.00 |
| Sep 30, 2017 | -283,000.00 |
| Jun 30, 2017 | 7.66 Mn |
| Jun 30, 2017 | 7.66 Mn |
| Mar 31, 2017 | 771,000.00 |
| Mar 31, 2017 | 771,000.00 |
| Dec 31, 2016 | -100,000.00 |
| Dec 31, 2016 | -100,000.00 |
| Sep 30, 2016 | -51,000.00 |
| Sep 30, 2016 | -51,000.00 |
| Jun 30, 2016 | -1.54 Mn |
| Jun 30, 2016 | -1.54 Mn |
| Mar 31, 2016 | 1.27 Mn |
| Mar 31, 2016 | 1.27 Mn |
| Dec 31, 2015 | 3.63 Mn |
| Dec 31, 2015 | 3.63 Mn |
| Sep 30, 2015 | 1.95 Mn |
| Sep 30, 2015 | 1.95 Mn |
| Jun 30, 2015 | 941,000.00 |
| Jun 30, 2015 | 941,000.00 |
| Mar 31, 2015 | -2.17 Mn |
| Mar 31, 2015 | -2.17 Mn |
| Dec 31, 2014 | 1.51 Mn |
| Dec 31, 2014 | 1.51 Mn |
| Sep 30, 2014 | -330,000.00 |
| Sep 30, 2014 | -330,000.00 |
| Jun 30, 2014 | 56,000.00 |
| Jun 30, 2014 | 56,000.00 |
| Mar 31, 2014 | 4.22 Mn |
| Mar 31, 2014 | 4.22 Mn |
| Dec 31, 2013 | -1.62 Mn |
| Dec 31, 2013 | -1.62 Mn |
| Sep 30, 2013 | -548,000.00 |
| Sep 30, 2013 | -548,000.00 |
| Jun 30, 2013 | -226,000.00 |
| Jun 30, 2013 | -226,000.00 |
| Mar 31, 2013 | 1.23 Mn |
| Mar 31, 2013 | 1.23 Mn |
| Dec 31, 2012 | -1.70 Mn |
| Dec 31, 2012 | -1.70 Mn |
| Sep 30, 2012 | 1.76 Mn |
| Sep 30, 2012 | 1.76 Mn |
| Jun 30, 2012 | -407,000.00 |
| Jun 30, 2012 | -407,000.00 |
| Mar 31, 2012 | 345,000.00 |
| Mar 31, 2012 | 345,000.00 |
| Dec 31, 2011 | 3.07 Mn |
| Dec 31, 2011 | 3.07 Mn |
| Sep 30, 2011 | 417,000.00 |
| Sep 30, 2011 | 417,000.00 |
| Jun 30, 2011 | -1.72 Mn |
| Jun 30, 2011 | -1.72 Mn |
| Mar 31, 2011 | -1.44 Mn |
| Mar 31, 2011 | -1.44 Mn |
| Dec 31, 2010 | 2.06 Mn |
| Dec 31, 2010 | 2.06 Mn |
| Sep 30, 2010 | 557,000.00 |
| Sep 30, 2010 | 557,000.00 |